Prevalence of Fatigue and Associated Factors Among Adult Cancer Patients Attending Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia, 2019.
| dc.contributor.advisor | Berhe Semarya( Prof) | |
| dc.contributor.advisor | Tesfaye Jembere(MSc) | |
| dc.contributor.author | G/her Teka | |
| dc.date.accessioned | 2020-06-04T18:35:26Z | |
| dc.date.accessioned | 2023-11-06T08:51:10Z | |
| dc.date.available | 2020-06-04T18:35:26Z | |
| dc.date.available | 2023-11-06T08:51:10Z | |
| dc.date.issued | 2019-06 | |
| dc.description.abstract | Background: Fatigue is a common distressing problem in most cancer patients. It may be caused by the disease, the complications of the disease and its treatments. This study aimed to assess prevalence of fatigue and associated factors among adult cancer patients receiving various treatment. A cross sectional study was conducted on 278 patients from February 2019 to march 2019 in TASH Cancer Center. Brief Fatigue Inventory (BFI) scale was used for assessment of fatigue, other questions were concerning the socio-demographic data, medical condition and clinical factor included. Objectives: was to assess the prevalence of fatigue and associated factors among cancer patients February and March 2019, at TASH in Addis Ababa, Ethiopia. Methods: A cross-sectional study design was used among 278 randomly selected cancer patients undergoing cancer treatment at TASH. A standardized data collection tool, Brief Fatigue Inventory (BFI) was used to gather information from participants. The data was entered to EPI-data version 3.1 and transferred to SPSS version 24 for analysis. Bivariate and multivariable logistic regression were conducted to summarize the data. Level of confidence was determined at 95% CI and p-value <0.05 was considered significant for associations. Result: The prevalence of fatigue among cancer patients in this study showed (74.8%). Age AOR=3.15[1.352-7.336], stage of cancer, AOR: 0.022, [0.0030-0.172], presence of infection, AOR: 4.153 [1.064-16.069], type of cancer AOR= 5.189 [1.590-16.9], and type of treatment AOR: 0.177 [0.068-0.46] showed significant association with fatigue. Conclusion and Recommendation: The prevalence of fatigue among cancer patients undertaking cancer treatment in this study is high. Patients undergoing radiotherapy and chemotherapy demonstrated higher fatigue symptoms than the other treatment modalities. Age, stage of cancer, type of cancer, type of treatment and infection were associated with fatigue. Therefore, especially nurses and physician could be work on how to reduce fatigue at all levels of patient care. The total cost of the study was 25000.09 ETH Birr. | en_US |
| dc.identifier.uri | http://etd.aau.edu.et/handle/123456789/21429 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Addis Ababa University | en_US |
| dc.subject | Fatigue prevalence, cancer patients. | en_US |
| dc.title | Prevalence of Fatigue and Associated Factors Among Adult Cancer Patients Attending Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia, 2019. | en_US |
| dc.type | Thesis | en_US |